Luke Lado

Experience: Representative Matters: Advised BeOne Medicines, the Nasdaq-listed biotech company, on a pioneering financing comprising a Renminbi-denominated term loan facility of 2.15 billion, alongside a U.S. dollar-denominated term loan facility of US$560 million, and U.S. dollar-denominated revolving loan facility of US$140 million.; Advised Nomad Foods Group, Europe's leading frozen food business, on the refinancing of its term loan B facilities of US$620 million and 880 million, and its multicurrency revolving credit facility of 175 million.; Representation of Hilco Capital in relation to its special situations investment in Design Group Americas, Inc.; Representation of Cheyne SVC on its private credit investment in LuxVet Group.; Representation of Praana Group in connection with the acquisition finance elements of its definitive agreement to acquire Owens Corning's (NYSE: OC) glass reinforcements business at an enterprise value of $755 million.; Represented Nomad Foods, Europe's leading frozen food company, in relation to the successful repricing of its Term Loan B facilities.; Represented the ad hoc committee of lenders in relation to the US$6.3 billion debt restructuring of Nordic Aviation Capital.; Represented the lenders in relation to the provision of debt finance to Oakley Capital regarding its investments in Phenna Group.; Represented a cinema conglomerate regarding a special situations debt financing.; Represented the lender in relation to Eurazeo's refinancing of DORC.; Represented Thomas Cook in relation to new money options and a restructuring of its debt.; Represented Morgan Stanley in relation to the provision of bridge to bond financing regarding the 450 million acquisition of Axelos by PeopleCert.; Represented the ad hoc committee of senior lenders in relation to new money options and the debt restructuring of the Curaeos group, an EQT owned business based in the Netherlands.; Represented the lenders and equity holders in relation to the restructuring and special situations financing of the Prezzo group and its subsequent sale to Cain International.; Represented the ad hoc committee of senior lenders regarding the provision of new money to the Fatface group and the restructuring of the group's existing debt.; Represented UBS and another lender in relation to the provision of acquisition finance to Aristocrat Leisure regarding the acquisition of Playtech plc.; Represented the lenders in relation to the provision of special situations debt financing to Folli Follie.; Represented the lenders regarding the cross over credit financing of Flutter Entertainment plc in light of its merger with Stars Group Inc.; Represented Smile Telecom in relation to a restructuring of its debt.; Represented a leading private equity house and its English portfolio company regarding a complex special situations financing in light of COVID-19.; Represented the mandated lead arrangers in relation to term loan B refinancing facilities provided to the Galileo Education Group.; Represented the mandated lead arrangers and underwriters in connection with the senior secured notes and super senior financing for Bite group in the Baltic region.; Represented Credit Suisse in relation to margin loans.; Represented debt funds in relation to subscription line facilities.; The above representations were handled by Mr. Lado prior to his joining Greenberg Traurig, LLP.